By Renee Botello MSc, Treatment and Trials Navigator A lung cancer diagnosis can be overwhelming and is life-changing for patients and caregivers. Navigating it is challenging without the correct information. The internet has become many people's primary [...]
By Renee Botello MSc, Navigator, Treatment and Trials, GO2 for Lung Cancer and Roy Herbst, MD, PhD Each year, the American Society of Clinical Oncology (ASCO) holds an annual meeting that shares novel breakthroughs and transformative research in oncology. [...]
Lung cancer mortality has been declining steadily in the past two decades and the good news is the pace of the improvements have picked up! Last week, the American Cancer Society released their 2022 stats and share that the [...]
The World Health Organization defines a clinical trial as “a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.” Put simply, it’s a research study involving people, often used to evaluate [...]
By Jennifer C. King, PhD, Chief Scientific Officer I’m an optimist at heart -- to the point where my tween daughter just rolls her eyes at me whenever I tell her to have a more positive attitude. Consequently, while [...]
The GO2 for Lung Cancer is honored to announce that on May 2 two of our programs received Your Cancer’s Cancer Community (C2) Awards. These awards celebrate “the unsung heroes of cancer care” – individuals and organizations that advance [...]
Dear Lung Cancer Community, As we dive into 2019 and further our efforts to advance new life-saving research and treatments for the lung cancer community, we want to take a moment to say thank you and reflect on what [...]
Last year was an exciting year for lung cancer research with more U.S. Food and Drug Administration (FDA) approval decisions relevant to lung cancer than ever before. So, what can we expect for 2019? Another eventful year with researchers [...]
The Lung Cancer Alliance team is heading to IASLC's World Conference on Lung Cancer (WCLC), Toronto, Canada from September 23-28, 2018 and will be presenting on hot topics in the field of lung cancer including: clinical trials, long-term survivorship, stigma, [...]
